Characterization of the novel HLA-DRB3*02:02:17 allele by sequencing-based typing.

Alleles Base Sequence Exons / genetics HLA-DRB3 Chains / genetics Histocompatibility Testing Humans
HLA-DRB3*02:02:17 HLA novel allele sequencing-based typing

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
08 2019
Historique:
received: 24 04 2019
revised: 01 05 2019
accepted: 02 05 2019
pubmed: 6 5 2019
medline: 21 5 2020
entrez: 7 5 2019
Statut: ppublish

Résumé

HLA-DRB3*02:02:17 differs from HLA-DRB3*02:02:01:01 by one nucleotide substitution in codon 179 in exon 3.

Identifiants

DOI: 10.1111/tan.13566 PMID: 31056835
pubmed: 31056835
doi: 10.1111/tan.13566
doi:

Substances chimiques

HLA-DRB3 Chains 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

170-171

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Marine Cargou (M)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
UMR CNRS 5164 Immunoconcept, Université de Bordeaux, Bordeaux, France.

Marco Andreani (M)

Laboratorio d'Immunogenetica dei Trapianti, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy.

Mariarosa Battarra (M)

Laboratorio d'Immunogenetica dei Trapianti, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy.
ORCID: 0000-0002-7506-2383

Gwendaline Guidicelli (G)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.

Jonathan Visentin (J)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
UMR CNRS 5164 Immunoconcept, Université de Bordeaux, Bordeaux, France.
ORCID: 0000-0003-3795-8979

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Characterization of the novel...
questionsmedicales.fr › Sciences de l'information › Sources d'information › Services d'information › Documentation › Données de séquences moléculaires › Séquence nucléotidique › Characterization of the novel...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Composants de gène › Exons › Characterization of the novel...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-D › Antigènes HLA-DR › Chaines bêta des antigènes HLA-DR › Chaines HLA-DRB3 › Characterization of the novel...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Tests immunologiques › Test d'histocompatibilité › Characterization of the novel...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Characterization of the novel...